$100 million open innovation challenge to find and fund ideas to accelerate detection of breast cancer and enable more personalised treatment
New mobile mammography concept SenoCase™ to transform access to screening in underserved areas
SenoBright™, an exclusive imaging technique, improves accuracy of breast exams and helps doctors better identify patients who need biopsies
GE to invest $1 billion on cancer R&D over five years
Formation of cancer coalition in Australia to expand access to mammography screening and breast cancer technology
* Agreement covers intellectual property relating to biopharmaceutical manufacturing technologies
Aubagne, France; Goettingen, Germany and Chalfont St. Giles, UK - September 12, 2011 -- Sartorius Stedim Biotech has entered into a patent cross-licensing agreement with GE Healthcare Life Sciences. This will enable the further development of each company's current and future biopharmaceutical manufacturing technologies.
business unit
tags
Adopted by more than 100 leading clinicians worldwide, Alcyone technology has become an accepted technology for nuclear cardiology diagnosis
Harnessing four advanced nuclear imaging innovations, Alcyone technology has the ability to reduce scan time and/or injected dose while maintaining image quality †
business unit
tags
IDA World Congress on Desalination and Water Reuse 2011
Booth C17, GE Power & Water
PERTH, AUSTRALIA---September 6, 2011---At this week's International Desalination Association (IDA) World Congress on Desalination and Water Reuse 2011 in Perth, GE (NYSE: GE) will showcase how its advanced desalination and other water reuse technologies help industrial and municipal customers responsibly convert seawater into clean water supplies for commercial and public uses.
business unit
tags
(IDA World Congress) PERTH, AUSTRALIA---September 6, 2011---GE (NYSE: GE), a global leader in water and process technologies, and Osmoflo, the largest Australian owned desalination and water recycling company in Australia, today unveiled a strategic alliance. The agreement will enable Osmoflo to expand its product portfolio and allow GE to deepen its presence in the Australian water market.
business unit
tags
Sydney, Australia -- 1 September, 2011 - GE (NYSE:GE) today announced that it has joined Virgin Australia and a consortium of other partners to research and develop commercial biofuel for the aviation industry. The consortium will focus on pyrolytic conversion of biomass from mallee eucalypt trees and intend to have a pilot biofuel production unit operating in Australia by 2012.
business unit
tags
Funded by Verve Energy, GE Energy Financial Services and WA Government, 10-megawatt project will use First Solar PV modules
Geraldton, Western Australia, Aug. 31, 2011 --- First Solar, Inc. (Nasdaq: FSLR), Verve Energy and GE (NYSE: GE) unit GE Energy Financial Services announced today that Australia's first utility-scale solar power project is under way. Output from the 10-megawatt AC project on 80 hectares of cleared land 50km southeast of Geraldton will contribute to offsetting the energy requirements of the Southern Seawater Desalination Plant.
business unit
GE's PET/CT +MR technology may hold promise in management of cancer, neurodegenerative and cardiac diseases
WAUKESHA, WI August 30, 2011---Hong Kong Sanatorium & Hospital (HKSH) has selected GE Healthcare's tri-modality imaging solution---PET/CT+MR---which may potentially enhance the ability of physicians to manage certain diseases.